Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
1.720
-0.210 (-10.88%)
At close: Oct 23, 2026, 4:00 PM EDT
1.700
-0.020 (-1.16%)
After-hours: Oct 23, 2026, 4:00 PM EDT
Xenetic Biosciences Employees
Xenetic Biosciences had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Xenetic Biosciences the 43,846th largest employer in the world and 7,276th in the United States.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,630,389
Profits / Employee
-$1,237,547
Market Cap
4.03M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | -2 | -50.00% | 2 | 0 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2021 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Enlivex | 34 |
| AIM ImmunoTech | 21 |
| NeuroSense Therapeutics | 17 |
| Cardio Diagnostics Holdings | 17 |
| Azitra | 13 |
| NuCana | 12 |
| Lexaria Bioscience | 7 |
XBIO News
- 9 days ago - Xenetic, PeriNess announce first patient dosed in DNase with CAR T cells study - TheFly
- 9 days ago - Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells for Large B-Cell Lymphoma - Accesswire
- 5 weeks ago - Xenetic Biosciences Transcript: M&A announcement - Transcripts
- 5 weeks ago - Xenetic Biosciences Press release: M&A announcement - Filings
- 5 weeks ago - Xenetic Biosciences Slides: M&A announcement - Filings
- 5 weeks ago - Xenetic, Santerus enter definitive share exchange agreement - TheFly
- 5 weeks ago - Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics - Accesswire
- 5 weeks ago - Xenetic Biosciences Slides: Investor presentation - Filings